BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34424263)

  • 21. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
    Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells.
    Chin HK; Horng CT; Liu YS; Lu CC; Su CY; Chen PS; Chiu HY; Tsai FJ; Shieh PC; Yang JS
    Oncol Rep; 2018 May; 39(5):2351-2357. PubMed ID: 29565448
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Cho HD; Kim JH; Park JK; Hong SM; Kim DH; Seo KI
    Pharm Biol; 2019 Dec; 57(1):684-693. PubMed ID: 31608754
    [No Abstract]   [Full Text] [Related]  

  • 24. MSCs inhibits the angiogenesis of HUVECs through the miR-211/Prox1 pathway.
    Pan J; Wang X; Li D; Li J; Jiang Z
    J Biochem; 2019 Jul; 166(1):107-113. PubMed ID: 31143937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RasGRP1 is a target for VEGF to induce angiogenesis and involved in the endothelial-protective effects of metformin under high glucose in HUVECs.
    Xu J; Liu M; Yu M; Shen J; Zhou J; Hu J; Zhou Y; Zhang W
    IUBMB Life; 2019 Sep; 71(9):1391-1400. PubMed ID: 31120617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardamonin Regulates miR-21 Expression and Suppresses Angiogenesis Induced by Vascular Endothelial Growth Factor.
    Jiang FS; Tian SS; Lu JJ; Ding XH; Qian CD; Ding B; Ding ZS; Jin B
    Biomed Res Int; 2015; 2015():501581. PubMed ID: 26266258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells.
    Abedi H; Zachary I
    J Biol Chem; 1997 Jun; 272(24):15442-51. PubMed ID: 9182576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic anti-hepatoma effect of bufalin combined with sorafenib via mediating the tumor vascular microenvironment by targeting mTOR/VEGF signaling.
    Wang H; Zhang C; Chi H; Meng Z
    Int J Oncol; 2018 Jun; 52(6):2051-2060. PubMed ID: 29620259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR‑3133 inhibits proliferation and angiogenesis by targeting the JUNB/VEGF pathway in human umbilical vein endothelial cells.
    Xu M; Cao L; Zhang X; Zhuang Y; Zhang Y; Wang Q; Chen Y; Xu L; Sun G
    Oncol Rep; 2020 Oct; 44(4):1699-1708. PubMed ID: 32945523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
    Wu DW; Cheng YW; Wang J; Chen CY; Lee H
    Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
    Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
    Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats.
    Li Z; Li J; Zhu L; Zhang Y; Zhang J; Yao L; Liang D; Wang L
    Int J Nanomedicine; 2016; 11():6135-6148. PubMed ID: 27920521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy.
    Zou J; Liu KC; Wang WP; Xu Y
    Life Sci; 2020 Sep; 256():117888. PubMed ID: 32497630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxycycline-mediated inhibition of corneal angiogenesis: an MMP-independent mechanism.
    Su W; Li Z; Li F; Chen X; Wan Q; Liang D
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):783-8. PubMed ID: 23249709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circular RNA-ZNF609 regulates corneal neovascularization by acting as a sponge of miR-184.
    Wu P; Zhang D; Geng Y; Li R; Zhang Y
    Exp Eye Res; 2020 Mar; 192():107937. PubMed ID: 31954666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
    Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
    Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-level laser therapy induces human umbilical vascular endothelial cell proliferation, migration and tube formation through activating the PI3K/Akt signaling pathway.
    Li Y; Xu Q; Shi M; Gan P; Huang Q; Wang A; Tan G; Fang Y; Liao H
    Microvasc Res; 2020 May; 129():103959. PubMed ID: 31734375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.